Lexaria BioscienceLEXX
13F holders, Q4 2024 (December 31)25holders −2
3new positions
6sold out
$2.10avg. 13F price*
At the end of Q4 2024, 25 institutions reported holding Lexaria Bioscience Corp. (LEXX) in their 13F filings, down 2 from Q3 2024. 3 opened new positions and 6 sold out. The largest holders were Armistice Capital, LLC ($966K), Invenomic Capital Management LP ($863K) and Geode Capital Management, LLC ($350K).
- Company
- Lexaria Bioscience Corp.
- CUSIP
- 52886N406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $987K |
| Exits | 6 | $345K |
All 13F filers, Q3 2024 → Q4 2024: 537,514 shares bought and 181,087 shares sold, net +356,427 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| Armistice Capital, LLC | 0.02% | New | 460,000 | $966K |
| Invenomic Capital Management LP | 0.05% | Reduce -13.7% | 410,731 | $863K |
| Geode Capital Management, LLC | 0.00% | Add +10.8% | 166,679 | $350K |
| Vanguard Group Inc. | 0.00% | Add +16.9% | 127,433 | $268K |
| Raymond James Financial Inc. | 0.00% | — | 60,640 | $127K |
| State Street Corp. | 0.00% | No change | 39,301 | $83K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | Add +108.9% | 28,873 | $61K |
| BlackRock, Inc. | 0.00% | No change | 27,445 | $58K |
| HighTower Advisors, LLC | 0.00% | Add +61.4% | 21,023 | $44K |
| Morgan Stanley | 0.00% | Reduce -12.0% | 20,229 | $42K |
| Northern Trust Corp. | 0.00% | No change | 18,389 | $39K |
| Bank of Montreal | 0.00% | No change | 14,000 | $29K |
| Byrne Asset Management LLC | 0.02% | Add +132.1% | 13,000 | $27K |
| Scotia Capital Inc. | 0.00% | New | 10,000 | $21K |
| Royal Bank of Canada | 0.00% | No change | 7,283 | $15K |
| Oakworth Capital, Inc. | 0.00% | No change | 5,000 | $11K |
| Wells Fargo & Company | 0.00% | Add +60.0% | 4,000 | $8K |
| R Squared Ltd | 0.01% | — | 2,620 | $6K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,290 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +54.9% | 2,082 | $4K |
| Farther Finance Advisors, LLC | 0.00% | No change | 166 | $349 |
| Bank of America Corp. | 0.00% | Add +9.6% | 126 | $265 |
| UBS Group AG | 0.00% | New | 116 | $244 |
| Sound Income Strategies, LLC | 0.00% | No change | 22 | $47 |
| Gables Capital Management Inc. | 0.00% | No change | 13 | $27 |
"% of holder's portfolio" is LEXX's weight in each manager's 13F, not the share of Lexaria Bioscience Corp. the manager owns.